Biotech
AbCellera
AbCellera raises $555M Series B at $5.7B valuation
2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, CanadaJune 12, 20241 min read
Total Raised
$555M
Valuation
$5.7B
Latest Round
Series B
Employees
400+
AbCellera: Series B Funding Round
AbCellera has successfully raised $555M in Series B funding, reaching a valuation of $5.7B.
Company Overview
Antibody discovery platform
Funding Details
The Series B round was led by Peter Thiel, with participation from Eli Lilly, Fast Forward Innovations, DCVC Bio.
Company Information
- Headquarters: 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada
- Founded: 2012
- Employees: 400+
- Category: Biotech
Investment
AbCellera plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Peter Thiel: Verified investor in Series B
- Eli Lilly: Verified investor in Series B
- Fast Forward Innovations: Verified investor in Series B
- DCVC Bio: Verified investor in Series B
Company Info
Headquarters
2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada
Founded
2012
Team Size
400+
Last Round
$555M(Jun 2024)
Investors (4)
P
Peter ThielLeadLead Investor
Verified investor in Series B
E
Eli LillyInvestor
Verified investor in Series B
F
Fast Forward InnovationsInvestor
Verified investor in Series B
D
DCVC BioInvestor
Verified investor in Series B
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free